BISMUSAL- bismuth subsalicylate suspension

BISMUSAL by

Drug Labeling and Warnings

BISMUSAL by is a Animal medication manufactured, distributed, or labeled by Durvet, Inc.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

INDICATIONS & USAGE

FOR ANIMAL USE ONLY

KEEP OUT OF REACH OF CHILDREN

FOR ORAL USE ONLY

INDICATIONS

A palatable oral suspension for use as an aid in the control fo simple diarrhea in cattle, horses and dogs.

CONTRAINDICATIONS

Not recommended for use in cats.

CAUTION

This product contains salicylate; do not administer with other salicylate-containing products, such as aspirin.

DOSAGE AND ADMINISTRATION

Administer orally after the first sign of diarrhea and after each loose bowel movement or as needed.

Dogs- 1 to 3 tablespoonfuls

Calves- 3 to 4 ounces

Foals- 3 to 4 ounces

Cattle and Horses- 6-10 fl. ozs.

This product may cause stools to darken.  If diarrhea persists after using this product for 2 days contact veterinarian.

COMPOSITION

Bismuth Subsalicylate ...... 1.75%

in a palatable aqueous suspension.  Flavoring and coloring added.

STORAGE AND HANDLING

SHAKE WELL BEFORE USING

Store at room temperature and not above 37°C (98.6°F)

Protect from freezing.

TAKE TIME OBSERVE LABEL DIRECTIONS

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

BISMUSAL 
bismuth subsalicylate suspension

Product Information
Product Type	OTC ANIMAL DRUG	Item Code (Source)	NDC: 30798-334
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
BISMUTH SUBSALICYLATE (UNII: 62TEY51RR1) (BISMUTH CATION - UNII:ZS9CD1I8YE)	BISMUTH SUBSALICYLATE	66.2 mg  in 3.785 L

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 30798-334-35	3.785 L in 1 JUG

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved drug other		06/21/2002

Labeler - Durvet, Inc. (056387798)